Canada cannabis stocks hit US highs

Canada cannabis stocks hit US highs
Canadian cannabis companies have hit new highs on Wall Street as US investors seek to catch the buzz from their northern neighbours.

With recreational use of marijuana due to be legalised in Canada on 17 October, producers Tilray and Canopy have seen their US-listed stocks surge.

Another firm, Aurora Cannabis, has said it will seek a US listing next month.

But analysts caution the stocks are overvalued and the gains could vanish in a puff of smoke.

In the opening minutes of Thursday trading, Nasdaq-listed medical marijuana firm Tilray, which went public in July, rose nearly 12% to $239.63 before falling back slightly.

On Wednesday, it was one of the best-performing US stocks, rising 38%.

However, trading in its shares was so volatile that it had to be halted five times during Wednesday s session.

Canopy Growth rose 2.8% in early Thursday trading. Its share price is still twice what it was six months ago, at around the $50 mark.

In the wake of their success, Alberta-based Aurora, whose shares were up 4% on the Toronto stock exchange on Thursday, is keen to have a presence on a major US exchange.

Aurora hit the headlines earlier this week when reports surfaced that about developing marijuana-infused beverages.

Financial analysts warned, however, that the shares were essentially commodity stocks and that the gains might prove short-lived.

In the case of Tilray, its share price "is now up over 1,100% in two months since the IPO", said in a note to investors.
News Topics :
Similar Articles :
Investors are craving marijuana stocks as Canada prepares to legalize pot next month, leading to giant gains for Canada based companies listed on U.S. exchanges. Some experts are concerned that the...
MedReleaf Corp. tumbled as much as 28 percent in the worst trading debut for a Canadian IPO in 16 years amid growing concern that pot stocks are overvalued. Shares in...
Canopy Growth Corp, Canada s biggest marijuana producer, said on Wednesday its third quarter revenue doubled and profit rose, even as analysts expected a loss. Net profit rose to $11 million from...
On Wednesday, Bruce Linton, Canopy Growth CEO sold the first legal recreational cannabis in Canada at the stroke of midnight at Tweed in St. John s, Newfoundland. He said that...
Cannabis short sellers made over $450 million on the first two days of the week, cutting nearly a third off their year to date losses, according to data from financial analytics firm...